NovelStem International Corp. (NSTM)
0.0095
0.00 (0.00%)
USD |
OTCM |
Sep 01, 16:00
NovelStem International Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2012 | 0.6399M |
| December 31, 2011 | 2.345M |
| December 31, 2010 | 2.641M |
| December 31, 2009 | 2.569M |
| December 31, 2008 | 3.324M |
| December 31, 2007 | 6.286M |
| December 31, 2006 | 7.204M |
| December 31, 2005 | 4.779M |
| Date | Value |
|---|---|
| December 31, 2004 | 5.138M |
| December 31, 2003 | 5.347M |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | 3.976M |
| Summit Therapeutics, Inc. | 537.67M |
| Kezar Life Sciences, Inc. | 33.76M |
| Protara Therapeutics, Inc. | 42.49M |
| Clene, Inc. | 12.66M |